Life stress, mood disturbance, and elevated interleukin-6 in healthy older women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 54, Issue 9, 1999, Pages

  Lutgendorf, Susan K ^a   Garand, Linda ^b   Buckwalter, Kathleen C ^b   Reimer, Toni Tripp ^b   Hong, Sue Young ^b   Lubaroff, David M ^b  

^a E11 SSH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; AFFECTIVE NEUROSIS; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; STRESS;

EID: 0032869069     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/54.9.M434     Document Type: Article

References (44)

1. Kiecolt-Glaser JK, Glaser R, Shuttleworth EC, Dyer CS, Ogrocki P, Speicher CE. Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom Med. 1987;49:523-535.
2. Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med. 1991;53:345-362.
3. Vitaliano PP, Russo J, Young HM, Teri L, Maiuro RD. Predictors of burden in spouse caregivers of individuals with Alzheimer's disease. Psychol Aging, 1991;6:393-402.
4. Makinodan T, Hahn TJ, McDougall S, Yamaguchi DT, Fang M, Iida-Klein A. Cellular immunosenescence: an overview. Exp Gerontol. 1991;26:281-288.
5. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-181.
6. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y. Altered regulation of IL-6 production with normal aging. J Immunol. 1993;150:5219-5230.
7. Graeve L, Baumann M, Heinrich PC. IL-6 in autoimmune diseases. Clin Invest. 1993;71:664-671.
8. Roodman, G.D. Interleukin-6: an osteotrophic factor? J Bone Miner Res. 1992;7:475-478.
9. Merz H, Fliedner A, Orscheschek K, et al. Cytokine expression in T-cell lymphomas and Hodgkin's disease: its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol. 1991;139:1173-1180.
10. Nachbaur DM, Herold M, Manesch A, Huber H. Serum levels of interleukin-6 in multiple myeloma and other hematologic disorders: correlation with disease activity and other prognostic parameters. Ann Hematol. 1991;62:54-58.
11. Bauer J, Ganter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H, Volk B, Berger M. The participatory interleuken-6 in the pathogenesis of Alzheimer's Disease. Research in Immunol. 1992;143:650-657.
12. Van Snick JL. Interleukin-6: an overview. Ann Rev Immunol. 1990;8: 253-278.
13. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by Interleukin-6. Science. 1992;257:88-91.
14. Manolagas SC, Bellido T, Jilka RL. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130. Int J Immunopharmacol. 1995;17:109-116.
15. Manolagas SC, Jilka RL. Mechanisms of diseases: bone marrow, cytokines, and bone remodeling-emergency insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305-311.
16. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993;133:2523-2530.
17. Judd AM, McLeod RM. Adrenocorticotropin increases interleukin-6 release from rat adrenal zona glomerulosa cells. Endocrinology. 1992;130: 1245-1254.
18. Arimura A, Atsushi T, Komaki G. Interactions between cytokines and the hypothalamic-pituitary-adrenal axis during stress. Ann NY Acad Sci. 1994;739:276-281.
19. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci. 1995;762:474-476.
20. Light E, Liebowitz BD. Alzheimer's Disease Treatment and Family Stress: Directions for Research. Rockville, MD: National Institute of Mental Health; 1989.
21. Fisher BJ. The stigma of relocation to a retirement facility. J Aging Studies. 1990;4:47-59.
22. Golant S.M. Matching congregate housing settings with a diverse elderly population: research and theoretical considerations. J Housing Elderly. 1991;9:21-38.
23. Aldrich CK, Mendkoff E. Relocation of the aged and disabled: a mortality study. J Am Geriatr Soc. 1963;11:401-408.
24. Lieberman MA. Relationship of mortality rates to entrance to a home for the aged. Geriatrics. 1961;16:515-519.
25. Carp FM. Short-term and long-term prediction of adjustment to a new environment. J Gerontol. 1974;29:444-453.
26. Armer J. Elderly relocation to a congregate setting: factors influencing adjustment. Issues Ment Health Nurs. 1993;14:157-172.
27. Bourestom N. Psychological and physiological manifestations of relocation. Psychiatric Med. 1984;2:57-90.
28. Ryff CD, Essex MJ. The interpretation of life experience and well-being: the sample case of relocation. Psychol Aging. 1992;7:507-517.
29. Averill JR. Personal control over aversive stimuli and its relationship to stress. Psychol Bull. 1973;80:286-303.
30. Kiecolt-Glaser JK, Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav Immun. 1988;2:67-78.
31. McNair DM, Lorr M, Droppleman LF. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
32. Curran SL, Andrykowski MA, Studts JL. Short form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess. 1995;7:80-83.
33. Doumas BT, Biggs HG. Determination of serum albumin. Standard Meth Clin Chem. 1972;7:175-188.
34. Cooper J, Garnder C. Effect of aging on serum albumin. J Am Geriatr Soc. 1989;37:1039-1042.
35. Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci. 1996;93:3043-3047.
36. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986; 7:284-301.
37. Gatti G, Cavallo R, Sartori ML, et al. Inhibition of human natural killer cell activity by cortisol. J Steroid Biochem. 1987;265:29-58.
38. Matta SG, Weatherbee J, Sharp BM. A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1β. Neuroendocrinology. 1992;56:516-525.
39. Waage A, Slupphaug G, Shalaby R. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells, and fibroblasts. Eur J Immunol. 1990;20:2439-2443.
40. DeRijk R, Michelson D, Karp B, et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1β (IL-1β), Il-6, and tumor necrosis factor (TNF-a) production in humans: high sensitivity of TNFa and resistance of IL-6. J Clin Endocrinol Metab. 1997;82:1-10.
41. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger MJ. Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver. Am J Physiol. 1995;268:R669-R706.
42. Costello N, Antoni M, Baldewicz T, Lutgendorf S, Klimas N, Schneiderman N. Coping and emotional expression effects upon distress, illness burden, and cytokines in CFS patients after Hurricane Andrew. Psychosom Med. 1998;60:121-122. (Abstract)
43. Cohen HJ, Pieper CF, Harris T, Rao KMK, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Med Sci. 1997;52A:M201-M208.
44. Berek JS, Chung C, Kaldi K, Watson HM, Knox RM, Martinez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol. 1991;164:1038-1042.